Pacific Edge, SCPMG to Evaluate Bladder Cancer Dx | GenomeWeb

NEW YORK (GenomeWeb) – Pacific Edge announced on Wednesday an agreement with the Southern California Permanente Medical Group for the evaluation of Pacific Edge's gene expression-based test for the detection of bladder cancer.

About 2,000 patients presenting with microscopic and macroscopic hematuria will be recruited as part of the Kaiser Permanente User Program research project, which is expected to begin later this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.